The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.
In vivo comparative study of hydroxyapatite labeled with different radioisotopes: evaluation of the scintigraphic images
R. M. Couto
M. F. De barboza
A. A. De souza
E. B. De araújo
Corresponding Author(s) : R. M. Couto
Cellular and Molecular Biology,
Vol. 56 No. 2: First symposium on internal dosimetry applied to nuclear medicine (DOSIMN) 2008 Part 2
Radyosinovectomy (RSV) is a radiotherapeutic modality where a Î²-emitting radionuclide is administered locally by intra-articular injection on the form of a colloid or radiolabeled particulate. RSV is a well-accepted therapeutic procedure in inflammatory joint diseases and has been successfully employed for more than 50 years as a viable alternative to surgical and chemical synovectomy. The aim of this work is to compare the in vivo stability of hydroxyapatite labelled with 177Lu, 90Y and 153Sm. All radionuclides were labelled with high yield and were retained in the joint for 7 days, showing stability and usefulness as tools in the RSV treatment. A similar retention of the products in the muscle was observed when the particles were administrated in the muscle. However, the pure form of the radionuclides were rapidly cleared from the blood and accumulated in the liver when injected i.v.. Although 153Sm-HA is already available for nuclear medicine procedures and clinical studies with 90Y-HA have been developed, 177Lu-labeled RSV agents will be economically more viable and has not been studied yet. Its favorable characteristics contribute to follow, to predict and asses the success of RSV by bone scintigraphy studies.
Couto, R. M., De barboza, M. F., De souza, A. A., Muramoto, E., Mengatti, J., & De araújo, E. B. (2010). In vivo comparative study of hydroxyapatite labeled with different radioisotopes: evaluation of the scintigraphic images. Cellular and Molecular Biology, 56(2), 6–11. Retrieved from https://cellmolbiol.org/index.php/CMB/article/view/996